
Keywords: CK; cytokeratins; BC; breast cancer; HER-2; human epidermal growth factor receptor-2; RT-PCR; reverse transcription followed by polymerase chain reaction; BBD; benign breast diseases; TNM; Classification of Malignant Tumors; ER; estrogen receptor; SBR; Sc